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1 abstract
Methods to efficiently determine the relative
stability of polymorphs of organic crystals are
highly desired in crystal structure predictions
(CSPs). Current methodologies include use
of static lattice phonons, quasi-harmonic ap-
proximation (QHA), and computing the full
thermodynamic cycle using replica exchange
molecular dynamics (REMD). We found that
13 out of the 29 systems minimized from ex-
periment restructured to a lower energy min-
ima when heated using REMD, a phenomena
that QHA cannot capture. Here, we present a
series of methods that are intermediate in ac-
curacy and expense between QHA and com-
puting the full thermodynamic cycle which
can save 42–80% of the computational cost
and introduces, on this benchmark, a rela-
tively small (0.16 ± 0.04 kcal/mol) error rel-
ative to the full pseudosupercritical path ap-
proach. In particular, a method that Boltz-
mann weights the harmonic free energy of
the trajectory of an REMD replica appears
to be an appropriate intermediate between
QHA and full thermodynamic cycle using
MD when screening crystal polymorph sta-
bility.
2 Introduction
Predicting the solid-solid stability of organic
crystals a priori is of great interest in the
materials design of pharmaceuticals, ener-
getic materials, and small molecule semi-
conductors. Polymorphism, the presence of
alternate packings in the solid phase, can lead
to significant difference in the physiochemical
and mechanical properties. It has been shown
that solubility,1–12 reactivity,13–15 and charge
transport16–20 can all be affected by the solid
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form. The appearance of new polymorphs in
the late stages of development can be par-
ticularly problematic and potentially require
reformulation.
A class of prediction algorithms gener-
ally classified as “crystal structure predic-
tions” (CSP) provide one avenue to deter-
mine solid stability, with recent emphasis on
using free energy to rank the generated crys-
tals. Given a molecule of interest, a CSP
exhaustively generates possible solid arrange-
ments and estimates their stability. The
most common way to generate structures is
through random or quasi-random generation
techniques,21–25 but annealing and genetic al-
gorithms have also been used.21,25 Once crys-
tals are generated, they are ranked on their
thermodynamic stability as an approxima-
tion as to how likely they are to crystal-
lize. Early development of CSPs relied on the
static lattice energy to rank crystals, which
would underestimate the importance of en-
tropic affects. But more recently free en-
ergy techniques that approximate the entropy
using harmonic phonons have been used for
CSPs25,26 and a significant focused has been
placed on developing and probing what free
energy techniques are necessary.27–32
The harmonic approximation (HA) is the
easiest way to include entropy by computing
the static lattice harmonic phonons, which
can be improved by considering thermal
expansion through the quasi-harmonic ap-
proximation (QHA). Given a lattice min-
imum crystal, the harmonic phonons can
be computed to determine the free energy
of the crystal at all temperatures of inter-
est.27,33–48 QHA more accurately represents
the temperature-dependent change in the
crystal than HA by including thermal expan-
sion, which is done by determining the crys-
tal volume that minimizes the free energy at
the specified temperature. Typically QHA
has been limited to isotropic expansion or
quasi-anisotropic expansion,28,30,49–51 but re-
cently we have developed methods to perform
anisotropic expansion.31 For a number of sys-
tems we have shown approximations that can
be made to anisotropic QHA so that QHA
only costs the user 7× the cost of perform-
ing isotropic QHA.32 The simplicity and low
computational cost of harmonic approaches
is desirable in a CSP where 50–200 struc-
tures could exist within 2.5 kcal/mol of the
global minimum and therefore screening at
some level for entropy contributions to sta-
bility is useful.
The exact free energy difference between
two crystals, given a molecular model, can
be determined by relating them along a ther-
modynamic cycle using molecular dynamics
(MD), but is prohibitively expensive. In
molecular dynamics two polymorphs are sim-
ulated with NPT simulations over a spec-
ified temperature range, and the free en-
ergy as a function of temperature is esti-
mated. These functions of G(T ) for each
polymorph can then be related by determin-
ing their free energy difference at a reference
temperature.29,30 One way that a reference
free energy can be computed is by simulat-
ing the crystal along the pseudosupercriti-
cal path (PSCP), which restrains the atoms
and removes all molecular interactions.29,52–55
At this final state the free energy difference
between “crystals” will be zero. The full
PSCP with MD approach is being used in a
CSP framework in an industrial settings (cur-
rently, only described in conference proceed-
ings), but the use of this technique is limited
due to the computational expense. A full
free energy determination using the PSCP
approach with MD can cost up to three or-
ders of magnitude more than QHA with even
classical fixed-charge potentials, let alone po-
larizable potentials.
The ability of MD, especially with replica
exchange or other enhanced sampling tech-
niques, to overcome crystal restructuring and
converge to a free energy minimum config-
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urational ensemble is the largest benefit ob-
tained from spending the comparatively large
computational cost (10–20K CPU hrs / poly-
morph). For a given potential, we have shown
that irreversible crystal restructuring away
from direct minimization of the experimental
crystal is a common phenomena when poly-
morphs are heated in MD.30,32,56 Further in-
vestigation by Dybeck et al. found that con-
figurational ensembles obtained from MD in-
clude many static lattice minimum, being
found in 8 of 12 polymorphic systems stud-
ied.56 Approaches like QHA cannot overcome
this barrier of restructuring, which can lead
to inaccurate stability ranking or large errors
(>1.0 kcal/mol) in the thermodynamics com-
puted with QHA relative to MD.32 Determin-
ing the structures characteristic of the cor-
rect free energy minima is critical for a CSP,
motivating the use of MD as a part of the
search. In particular, replica exchange molec-
ular dynamics (REMD) provides the most
robust way to overcome crystal restructur-
ing because it allows the crystal to be con-
stantly heated up and annealed throughout
the simulation. We have found that QHA
run from a minimum consistent with the re-
structured crystal in REMD introduces er-
ror less than 0.12 kcal/mol,32 leaving room
for an intermediate approach between QHA
and computing the full thermodynamic cycle.
The breakdown of the computational cost of
REMD+PSCP is reported in Figure 1 and
shows clear places where time can potentially
be saved.
Due to the frequency at which we see
crystal restructuring occur for pairs of poly-
morphs, we should logically conclude that
this behavior will be more common in a CSP,
which generates far more crystal structures
than are found in experimental databases.
Therefore, using REMD seems to be advis-
able when screening CSPs, but we can reduce
the temperature range over which REMD is
performed to save computational cost. In
previous work we ran REMD from 10 K to
250–400 K depending on the system of in-
terest. The benefit of running temperature
REMD below 100 K is to find an appropri-
ate lattice minimum for QHA and to com-
pare how QHA performs relative to REMD
at low temperatures, as discussed in our pre-
vious work.32 Running REMD down to 10
K may not be necessary for all polymorphs,
but previous work shows that for some sys-
tems energy minimizing trajectories at 10 K
produces energetically indistinguishable lat-
tice minima while minimizing from 50 K can
produce structures that differ by up to 0.24
kcal/mol.56 Figure 1 shows that the time
spent running replicas below 50 K (28%) and
between 50–100 K (10%) has a large con-
tribution to the overall computational cost,
as lower temperature replicas must be more
closely spaced together. By excluding tem-
peratures below 100 K, which are generally
not of practical interest, the computational
cost can be reduced by roughly 38% if one
only calculates down to the temperature at
which the the PSCP is performed.
Performing the PSCP contributes to 42%
of the computational cost of the determi-
nation of ∆G(T ) on average. This percent
will change if different PSCP paths are ap-
proaches are used, but the approximate per-
centage will in most cases be similar. If a
harmonic-based approach could be used in-
stead to connect the polymorph G(T ) curves,
there could be significant speed up with po-
tentially little error introduced if the systems
behaved harmonically below a given T . Even
if an approach did not perfectly capture the
exact MD-derived free energies, it could help
provide a screen to reduced the need for the
more computationally expensive full PSCP
approach. Ideally, we would be able to re-
move both the low temperature REMD sim-
ulations and the PSCP to reduce the compu-
tational cost by 80% with little cost to the
accuracy in the polymorph free energy dif-
3
Total time: 10-20K CPU hrs / polymorph
PSCP (42%) REMD (58%)
T<50K (28%)*
T<100K (38%)**Percentages are based on
  total computational time
Total time: 10-20K CPU hrs / polymorph
PSCP (42%) REMD (58%)
T<50K (28%)
T<100K (38%)
Figure 1: Computing the free energy differences of polymorphs using OPLS with PSCP and
REMD from 10 K up to 250–400 K costs 10,000–20,000 CPU hrs. On average, 42% of the
cost in ∆G is from PSCP and 38% is from running REMD from 10–100 K. In later sections
we discuss and show approximations to help reduce the overall computational cost by 80%.
These values are based on the actual output of the systems ran here and are dependent on
simulation length, force field used, scaling, and other factors. Percentages are based off of
total computational time.
ferences. In the remainder of this paper, we
explore various approximations to lower the
cost to compute ∆G(T ) and evaluate any sac-
rifices to the accuracy of PSCP.
3 Methods
3.1 Quasi-Harmonic Approxi-
mation
The quasi-harmonic approximation (QHA)
assumes that there is a single static lattice
that can be used to determine the free en-
ergy at any given temperature and pressure
of interest. In QHA we determine the lattice
geometry C that minimizes the free energy F
in eq 2 to determine the Gibbs free energy at
the temperature and pressure of interest.31,32
G(T, P ) = min
C
F (C, T, P ) (1)
F (C, T, P ) = U(C) + Av(C, T )
+ PV (2)
Where U is the crystal’s potential energy and
Av is the Helmholtz free energy of a harmonic
oscillator. Here we use the classical equation
for the vibrational free energy (Av) in eq 3
because we are using a classical potential.
Av =
∑
k
β−1 ln (βh¯ωk(V )) (3)
The vibrational free energy is a summation of
the 3×N vibrational phonons (ωk) of the crys-
tal lattice, where N is the number of atoms.
At higher temperatures the free energy dif-
ference between of QHA using classical and
quantum statistics should be negligible. To
solve eq 1 we determine the crystal thermal
expansion, ∂C
∂T
= ( ∂
2G
∂C2
)−1( ∂S
∂T
),31,32 and itera-
tively integrate and expand the lattice mini-
mum up to a temperature of interest.
The expense of QHA can be simplified by
assuming a one-dimensional anisotropic ther-
mal expansion in conjunction with the con-
stant Gru¨neisen parameter approximation.
For each set of lattice parameters (C) the lat-
tice phonons (ω) must be computed, which
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can be expensive if done exactly through di-
agonalization of the mass-weighted Hessian.
It has been shown that assuming a constant
Gru¨neisen parameter (γk = − 1ωk
∂ωk
∂η
) can be
used to determine how a particular phonon
changes due to a strain placed on the crys-
tal. This approach is shown to introduce er-
ror < 0.01 kcal/mol for the computed solid–
solid free energy differences.31 When we first
presented the method to compute the crys-
tal thermal expansion, we found that a 1D
thermal expansion based on a scaling of the
gradients at 0 K was a sufficient substitute
for the full anisotropic expansion. In the
1D-expansion approach, the anisotropic ex-
pansion at 0 K and the ratio of those rates
(κi) are used to determine the crystal expan-
sion (Ci(λ) = Ci(λ = 0) + κiλ(T )), which
are scaled by λ. To save on computational
resources, QHA is performed using both the
Gru¨neisen parameter and the anisotropic 1D-
expansion method.
3.2 Molecular Dynamics with
the Pseudo-Supercritical
Path
An absolute free energy difference between
polymorphs can be determined by computing
the free energy for restraining the atoms and
turning off the inter- and intramolecular in-
teractions at a reference temperature to com-
plete the thermodynamic cycle. In the cur-
rent work we use eq 4 to describe changes to
the potential energy function due to changes
in the harmonic restraints or interactions.
U(λ1, λ2, γ1, γ2) = γ
2
1(Uinter + Utors.)
+ γ2(Ubond + Uangle)
+
(
(1− λ1)2 1
2
kx,1 + (1− λ2)4 1
2
kx,2
)
(x− x0)2
(4)
Where the path the crystal follows to the
restrained non-interacting ideal gas state is
obtained by:
1. restraining the atoms (λ1 = 1 → 0)
with a force constant of kx,1;
2. turning off (γ1 = 1 → 0) the inter-
molecular interactions (Uinter) and tor-
sions (Utors.);
3. applying a second larger restraint (λ2 =
1 → 0) to the atoms with a force con-
stant of kx,1 + kx,2; and then
4. turning off (γ2 = 1→ 0) the bonds and
angles.
Temperature replica exchange molecular
dynamics (REMD) allows us to quickly con-
verge to the thermodynamic minimum at all
temperatures of interest. REMD will period-
ically exchange the states of the replica based
using the probability of observing the state in
the other replica. By exchanging neighbor-
ing temperatures, replicas, the crystal is con-
stantly annealing from high to low temper-
ature, allowing the system to reach a stable
thermodynamic state faster.57 The reduced
free energy (f) of each polymorph can be
computed using the Multistate Bennett Ac-
ceptance Ratio (MBAR), which estimates the
difference of β times the free energy most con-
sistent with the energies of the samples gener-
ated at each temperature.58 In eq 5 the Gibbs
free energy difference between polymorphs as
a function of temperature (∆G(T )) is deter-
mined by relating the reduced free energies
to the Gibbs free energy difference compute
with PSCP.
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∆Gij(T ) = kBT (∆fij(T )−∆fij(Tref )) + T
Tref
∆Gij(Tref ) (5)
3.2.1 Replacing PSCP with QHA
Once an appropriate lattice minimum is
found from REMD, one could in theory re-
place the reference free energy difference be-
tween polymorphs computed with PSCP by
performing QHA and using this value in eq 5,
assuming that the crystal was sufficiently har-
monic below a given temperature. Since an
accelerated sampling method such as tem-
perature REMD is required to overcome the
free energy barriers to even local restruc-
turing, it introduces significant error to use
QHA started from CSP- or experimentally-
minimized structures to determine the poly-
morph free energy differences without ad-
ditional REMD.32 However, we have shown
that the error in QHA is relatively small
(0.03–0.22 kcal/mol at the failure temper-
ature of QHA) if QHA starts from a lat-
tice minimum that is energy minimized from
a 10 K (or potentially somewhat higher T )
replica of REMD.32 In this approximation,
the speed of QHA is combined with the abil-
ity of REMD to converge on a thermody-
namic minimum and the statistical ensemble
that a static lattice representation like QHA
fails to capture.
3.2.2 Replacing PSCP with conforma-
tionally weighted HA
Using QHA as an approximation for PSCP
does save computational time, but requires
us to perform REMD down to low temper-
atures to find a lattice minimum and may
be limited to systems that vibrate around
a single molecular conformation. In our ex-
perience, finding a restructured lattice mini-
mum requires us to run REMD down to 10
K, which can be expensive as outlined above.
Additionally, at temperatures as low as 10
K, the conformationally flexible molecules
studied here are able to access multiple low-
energy configurations which have slightly dif-
ferent vibrational energies.32,56 The propen-
sity of the molecules to visit a number of
low-energy conformations will only increase
with larger and more complex molecules than
those tested here. Since QHA only considers
a single conformation, it is likely to diverge
significantly from the exact result obtained
with high-quality MD for systems with larger
molecular flexibility.
The reference free energy difference can be
directly estimated by averaging the probabil-
ities of the harmonic free energy of the config-
urations minimized from samples of a molec-
ular dynamics simulation. The full configu-
rational ensemble in a crystal can be reason-
ably represented by an ensemble of molecular
and geometric configurations, each of which
belongs to a particular harmonic well. By
Boltzmann weighting those harmonic free en-
ergies, we can estimate the absolute harmonic
energy of the system. Since we can collect
these configurations from a moderately high
temperature REMD simulation, we can over-
come issues of disorder that limit other har-
monic methods.59 In eq 6 we show how a ref-
erence free energy can be computed for a sin-
gle polymorph, which can be combined for
two polymorphs to approximate a ∆G(Tref )
for eq 5.
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G(Tref ) = −β−1 ln
(
N∑
i=1
exp (−βF (C, Tref , P ))
)
(6)
Where F is the harmonic free energy com-
puted from eq 2 for some specified N frames
of the trajectory at Tref . Each frame is ge-
ometry minimized by allowing the molecu-
lar coordinates to relax but keeping the box
fixed. When approximating ∆G(Tref ) with
this method N must be large that ∆G(Tref )
has converged within a desired precision, and
we explore the choice of N later in this paper.
This method also does not require a lat-
tice minimum to be found, but should be run
at a temperature such the error in the approx-
imate ∆G(Tref ) with respect to full molecu-
lar dynamics approaches is minimized, or at
least is smaller than the level of accuracy the
user requires. We point out that this method
likely over-counts states sampled within the
simulation, as we may incorporate multiple
configurations that may minimize to the same
minimum structure, but leave that approxi-
mation uncorrected at the present time.
3.3 Simulation Details
We evaluate our methods with the poly-
morphs of the molecules in Figure 2. The
experimental polymorphs are reported in ta-
ble S2 with their CCDC refcodes. Each
molecule was parameterized using the Mae-
stro ffld server for the OPLS2 fixed charge
potential. Topologies for all molecules are
available in supporting information of our
previous publication.32 All molecular systems
used supercells with between 6 to 48 unit
cells, as we have shown that there is signif-
icant (add number range) size dependence in
the QHA approximation, requiring at least a
moderate number of unit cells to capture32
For temperature REMD we chose temper-
atures between 10 K up to 250–400 K with
replica spacing such that the exchange prob-
ability between replicas was approximately
0.3. All crystals were run for 20 ns with a
time step of 0.5 fs as flexible harmonic bonds
were used. PSCP was run at a reference
temperature of 200 K for all polymorphs. A
reference structure was selected from PSCP
and NVT simulations were run at the fol-
lowing spacing for each section of the path:
∆λ1 = 0.05, ∆γ1 = 0.05, ∆λ2 = 0.01, and
∆γ1 = 0.02. The values of the harmonic
restraint force constants are kx,1 = 10
3 kJ
/ (mol · nm2) and kx,2 = 106 kJ / (mol ·
nm2). We have developed a code package
to setup, run, and analyze all results for
this method, which is available on GitHub
at http://github.com/shirtsgroup/
finite-temperature-crystal-scripts.30,60
All simulations were performed with GRO-
MACS 2019.3.
The quasi-harmonic approximation is per-
formed on the lattice minimum found by en-
ergy minimizing the experimental crystal and
found by energy minimizing the 10 K replica
of temperature REMD. We selected 5 ran-
dom configurations from the equilibrated 10
K NPT simulation from REMD and energy
minimized each one. For all polymorphs, all 5
lattice minimum were within 0.015 kcal/mol
of one another and the lowest energy struc-
ture was used to run QHA for the restruc-
tured crystal. All harmonic approximation
calculations were run using the Tinker molec-
ular modeling package 8.7. Here the lattice
minimum were found using xtalmin to a toler-
ance of 10−5 and the lowest energy minimum
was selected for QHA. QHA was performed
using our Python wrapper package that is
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Succinonitrile Resorcinol Benzene
Paracetamol PiracetamPyrazinamide Adenine Carbamazepine
Chlorpropamide Tolbutamide Aripiprazole
Figure 2: Molecules evaluated in this study.
available on GitHub at http://github.
com/shirtsgroup/Lattice_dynamics.31,32
An example input file is provided with the
Supporting Information.
Boltzmann-weighted HA was completed
by performing multiple instances of HA
on the fixed geometry configurations found
with REMD of the NPT molecular sim-
ulations. For the reference temperature
of interest, N configurations were se-
lected from the equilibrated replica and
the coordinates were optimized using Tin-
ker’s minimize command, which holds
the lattice geometry fixed. The har-
monic energy was then computed using our
GitHub package Lattice_dynamics and then
finite-temperature-crystal-scripts
was used to compute eq 6 and eq 5. Con-
vergence plots for each polymorph pair can
be found in the Supporting Information (Fig-
ures S 5–S 15).
4 Results and Discussion
4.1 The prevalence of crystal
restructuring impairs the
use of QHA independent of
MD
Of the crystals studied, almost half of them
restructured during the REMD simulation.
In previous work we have discussed the preva-
lence of crystal restructuring due to REMD
simulations and shown its affect on the error
between QHA and REMD+PSCP.32 With a
larger sub of crystals, we have found that 13
out of the 29 (45%) restructure to a more
stable thermodynamic crystal structure when
heated up and cooled down with REMD.
Crystal restructuring is generally due to sym-
metry breaking between unit cells in the
supercell.30,32,56 Since restructuring occurred
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for polymorphs of piracetam, adenine, pyrazi-
namide, succinonitrile, chlorpropamide, arip-
iprazole, and tolbutamide, REMD is required
to find stable thermodynamic minima re-
gardless of molecular flexibility. The specific
polymorphs to undergo restructuring due to
REMD are listed in the Supporting Informa-
tion (Table S 2).
The error in ∆GQHA(T = 300K)
for QHA relative to REMD+PSCP is
large (RMSE=0.81±0.21 kcal/mol), but can
be significantly reduced (RMSE=0.15±0.03
kcal/mol) if the restructured lattice minimum
is used. We ran QHA on the lattice minimum
found from energy minimizing both the ex-
perimental crystal and the 10 K REMD tra-
jectory. In previous work we compared the er-
ror in QHA to REMD+PSCP at Tmax, which
is the maximum temperature QHA can reach
while still staying at a free energy minimum
(satisfying eq 2).32 Since the polymorph free
energy differences for QHA are fairly linear
and we want to compare all our results at
300 K, we linearly extrapolated ∆G using the
last 50 K of QHA before Tmax. Using eq 7
we can determine the error in ∆G computed
with QHA to the full thermodynamic cycle
at 300 K.
RMSEapprox. =
√√√√ 1
n
n∑
i
(
∆G
Tref
approx.(T = 300K)−∆GPSCP (T = 300K)
)2
(7)
Here, ∆G
Tref
approx.(T = 300K) is the poly-
morph free energy difference at 300 K com-
puted with one of the approximations and
∆GPSCP (T = 300K) is the absolute free en-
ergy difference at 300 K using REMD+PSCP.
4.2 Characterizing reference
temperatures that mini-
mize error in the approx-
imation
The optimal temperature to compute a ref-
erence free energy difference between poly-
morphs is dependent on the approximation
used. In REMD+PSCP the free energy dif-
ference is independent of the reference tem-
perature (Tref ) that PSCP is computed at.
However, this is not the case for the approxi-
mations. In Figure 3 (top), the RMSEs (eq 7)
for the approximations are plotted as a func-
tion of the reference temperature used. For
REMD+QHA the RMSE decreases as Tref
increases and converges to the RMSE of QHA
performed on the restructured crystals. On
contrast, the RMSE of REMD+Boltzmann-
HA method remains at a roughly constant
minimum for reference temperatures of 100–
250 K, though there is variation for different
polymorphs shown in the Supporting Infor-
mation (Figures S 16–S 33).
Boltzmann-weighted HA is a more robust
method since the free energy difference can
be computed at all temperatures in which
REMD can be performed. In Figure 3(bot-
tom) the number of polymorph pairs(n) in-
cluded in the RMSE (eq 7) is shown as a step
plot. To highlight methodological errors in
the approximations, we have chosen not to
use reference free energy difference of poly-
morphs greater than Tmax in REMD+QHA.
At temperatures greater than 150 K the num-
ber of systems with usable QHA, as shown in
the step plot of REMD+QHA, starts to de-
crease, whereas REMD+Boltzmann-HA can
be performed at all temperatures. There is
a drop in the REMD+Boltzmann-HA step
plot at 250 K, but this is because benzene
cannot be simulated at higher temperatures
9
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Figure 3: The RMSE of the polymorph free energy differences at 300 K for all approxi-
mations relative to REMD+PSCP is shown (top) and the number of polymorph pairs in
that RMSE (n) is reported in the corresponding step plot (bottom) for different reference
temperatures (Tref ). We can determine a reference free energy difference at all temperatures
using REMD+Boltzmann-HA, whereas QHA becomes unusable due to numeric instability,
as shown in the step plot. The drop in number of free energy differences n for Boltzmann-HA
is solely because benzene is liquid above 250 K. REMD+Boltzmann-HA and (extrapolated)
QHA dependent of REMD produce the lowest error (RMSE=0.15 kcal/mol) at reference
temperatures that include all polymorph pairs (n =18). The solid line is solely QHA with
REMD restructuring and the dashed line is for QHA run from structures minimized from
experiment. Errors are the standard deviation of the bootstrapped error of the RMSE over
all n systems.
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as it starts to approach its simulated melting
point.
Using REMD+Boltzmann-HA or extrap-
olated QHA produces the smallest er-
ror (RMSE=0.15 kcal/mol) relative to
REMD+PSCP, with REMD+Boltzmann-
HA being the most stable. For all approxima-
tions we want to look at the minimum value of
the RMSE that is inclusive of all polymorph
pairs (n =18). In the case of REMD+QHA
this is at 150 K where the RMSE is 0.24±0.07
kcal/mol, which is 0.09 kcal/mol greater
than the RMSE of REMD+Boltzmann-HA
and extrapolated QHA, 0.15±0.02 kcal/mol.
REMD+Boltzmann-HA is the most robust
method because it 1) doesn’t require ex-
trapolation, and 2) errors remain with 0.02
kcal/mol of the minimum RMSE using refer-
ence temperatures between 100–250 K. The
optimal reference temperature and generated
error is both molecule and polymorph de-
pendent as seen in the Supporting Informa-
tion (Figures S 16 – S 33). Chlorpropamide
(Figure S 30) is a good example of this
phenomenon where the largest error (0.28
kcal/mol) for REMD+Boltzmann-HA is for
Tref = 200 K, but the smallest error (0.02
kcal/mol) is at Tref = 300 K, falling out-
side of the general range for all systems. If
it is feasible, determining a reference free en-
ergy difference at a couple of temperatures
with REMD+Boltzmann-HA may be benefi-
cial to determine the robustness the result to
the temperature reference.
The RMSE of the various approxima-
tions that use REMD are between 0.10–0.33
kcal/mol at 300 K, and are functions of the
size and flexibility. In Figure 4 the RMSE
for each approach is reported using Tref =
150 K in the bar plots and the systems
have been split by molecular flexibility, where
the flexible molecules are aripiprazole, chlor-
propamide, and tolbutamide. The largest
trend of error due to molecular flexibility
is for the error in the polymorph free en-
ergy differences of QHA run independently of
REMD. For the rigid systems 6 of the 21 poly-
morphs restructure, whereas 7 of the 8 more
flexible polymorphs restructure leading to the
larger RMSE for the flexible systems. The
error in the approximations that use REMD
are much smaller, but also trend with molec-
ular flexibility. We know that the flexible
molecules are able to access a greater number
of molecular conformations, which are most
evidently anharmonic since even the error in
REMD+Boltzmann-HA is increasing.
4.3 There are several ap-
proaches to choose from ap-
proximate the free energy
before computing the full
thermodynamic cycle
Boltzmann-weighted HA provides the most
efficient way to compute the polymorph
energy differences to still include the full
statistical ensemble from REMD. In ta-
ble 1 we report the error for each approx-
imation with their relative computational
times. Both approximations (REMD+QHA
& REMD+Boltzmann-HA) introduce sim-
ilar amounts of error (RMSE =0.15–
0.17 kcal/mol) relative to REMD+PSCP,
but REMD+Boltzmann-HA outperforms
REMD+QHA because it is able to eliminate
low temperature replica from REMD in ad-
dition to the PSCP. If the speed/accuracy
trade-off favors speed, QHA independent
of REMD is the fastest, but introduces
the most error relative to REMD+PSCP.
REMD+Boltzmann-HA may be ideal for an
initial screening of a CSP followed by using
PSCP on select low energy systems.
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Figure 4: The RMSE of the polymorph free energy differences at 300 K for all approxima-
tions relative to REMD+PSCP is shown for the rigid and flexible molecules. The flexible
molecules are aripiprazole, chlorpropamide, and tolbutamide. The error in restructuring
has the greatest difference between rigid and flexible molecules because 7 of the 8 flexible
polymorphs restructure, whereas only 6 of the 21 rigid polymorphs restructure. The value n
reported is the number of polymorph pairs between which free energies are calculated that
are included in the RMSE.
Table 1: Comparison of error in the polymorph ∆G at 300 K from REMD+PSCP and the
computational time for methods examined in this study. The RMSE is reported with the
bootstrapped error using a reference temperature of 150 K for REMD+Boltzmann-HA and
REMD+QHA. Boltzmann-weighted HA provides the most efficient method to determine the
free energy difference between polymorphs.
Method δ(∆G(T = 300K)) [kcal/mol] CPU hrs/poly.
REMD+PSCP (10–300 K) 0.0 10–20K
REMD+PSCP (100–300 K) 0.0 6.2–12.4K
REMD+QHA (10–300 K) 0.14±0.07 5.8–11.6K
REMD+Boltzmann-HA (100–300 K) 0.16±0.04 2–4K
QHA with REMD minima 0.15±0.03 5.8–11.6K
QHA without REMD minima 0.81±0.20 < 0.1K
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5 Conclusions
We present a range of approximations for pre-
dicting the free energy differences of poly-
morphs which can be easily be implemented
as a screening method for CSPs. We have
previously used the PSCP to determine an
absolute reference free energy difference to
complete a thermodynamic cycle between two
polymorphs.29,30,32 Here we approximate the
reference free energy difference using QHA
and a method that Boltzmann weights the
harmonic energy of frames from an NPT sim-
ulation. Two advantages of the Boltzmann-
weighted HA approach over QHA are: 1) that
low temperature replicas do not need to be
used and 2) that it can sample multiple min-
ima that may exist in the ensemble.
Boltzmann-weighted HA is a cheaper
method than PSCP that can be used to
screen crystal structures in a CSP. Free en-
ergy approximations have increasingly been
used in CSPs to rank generated structures.
The “gold standard” for free energy rank-
ings given a potential energy model is us-
ing REMD with the PSCP to compute a
full thermodynamic cycle between crystals,
but can be prohibitively expensive. By
combining the ability of REMD to over-
come barriers of crystal restructuring and the
speed of harmonic approaches we have de-
veloped a method to more efficiently screen
crystal structures. Our Boltzmann-weighted
HA method is 42–80% cheaper than us-
ing REMD+PSCP and introduces a rela-
tively small error of 0.15±0.04 kcal/mol. We
do note that this error is dependent on
the molecular flexibility, with 0.10±0.02 and
0.19±0.05 kcal/mol error in ∆G for rigid and
flexible molecules in our small benchmark,
respectively. This Boltzmann-weighted har-
monic method performs roughly comparably
to using free energies from QHA from REMD-
discovered minima to provide the reference
free energy, but it is both more robust and
faster. In contrast, QHA free energies mini-
mized directly from experiment can introduce
error as large as 0.81±0.20 kcal/mol relative
to REMD+PSCP. The Boltzmann-weighted
HA method appears to be a potentially use-
ful choice for initial screening of crystals in
a CSP to eliminate entropically disfavorable
crystals when PSCP is performed.
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6 Systems Studied
In Table 2 we provide the systems studied, their polymorphs name/numbering, corresponding
Cambridge Structure Database reference code (CSD Refcode), and the dimensions of the
supercells relative to the symmetric cell pulled from the database. Those systems that are
highlighted blue have different lattice minimum when energy minimized from experiment
and from the 10 K REMD simulation.
Piracetam Form I Form II Form III
CSD Refcode BISMEV03 BISMEV BISMEV02
Space Group P21/n P1¯ P21/n
Supercell Dimensions 4× 2× 3 2× 4× 3 2× 3× 4
Benzene Form I Form II Form III
CSD Refcode BENZEN11 BENZEN16 BENZEN04
Space Group Pbca P21/c P21/c
Supercell Dimensions 3× 2× 3 3× 3× 4 3× 4× 3
Carbamazepine Form I Form III Form IV
CSD Refcode CBMZPN11 CBMZPN02 CBMZPN12
Space Group P1¯ P21/n C2/c
Supercell Dimensions 4× 2× 1 4× 2× 2 1× 4× 2
Adenine Form I Form II
CSD Refcode KOBFUD KOBFUD01
Space Group P21/c Fdd2
Supercell Dimensions 3× 1× 4 3× 1× 2
Pyrazinamide Form α β Form γ Form δ
CSD Refcode PYRZIN14 PYRZIN01 PYRZIN20 PYRZIN16
Space Group P21/a P21/c Pc P1¯
Supercell Dimensions 1× 4× 6 2× 6× 2 4× 6× 2 4× 4× 3
Resorcinol Form α Form β
CSD Refcode RESORA03 RESORA08
Space Group Pna21 Pna21
Supercell Dimensions 2× 2× 4 2× 2× 4
Succinonitrile Form I Form III
CSD Refcode QOPBED N/A
Space Group P21/a N/A
Supercell Dimensions 2× 3× 4 N/A
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Paracetamol Form I Form II
CSD Refcode HXACAN01 HXACAN
Space Group P21/a Pcab
Supercell Dimensions 2× 2× 3 2× 1× 3
Aripiprazole Form I Form X
CSD Refcode MELFIT01 MELFIT05
Space Group P21 P21
Supercell Dimensions 3× 4× 2 3× 4× 2
Tolbutamide Form I Form II Form III Form V
CSD Refcode ZZZPUS04 ZZZPUS05 ZZZPUS09 ZZZPUS10
Space Group Pna21 Pc P21/n Pbcn
Supercell Dimensions 2× 3× 2 3× 2× 1 2× 3× 2 2× 3× 1
Chlorpropamide Form I Form V
CSD Refcode BEDMIG BEDMIG04
Space Group P212121 Pna21
Supercell Dimensions 1× 4× 2 1× 4× 2
Table 2: Table of systems studied in the main paper. We have included the polymorph names,
CSD reference codes, and the cell dimensions relative to the symmetric unit cell pulled down
from the database. If the cell is blue it indicates that the crystal energy minimized from
experiment is different from the crystal minimized from REMD.
7 Convergence of Boltzmann weighted HA frames
Determining a polymorph free energy difference with Boltzmann weighted HA for these
systems requires 10 – 40 frames from an NPT trajectory when using a reference temperature
between 50 – 300 K. Figures 5 – 15 show the change in the polymorph free energy differences
of each pair of polymorphs using our Boltzmann weighted HA method. The error in potential
energy differences of polymorphs when computed with GROMACS (MD simulations) and
Tinker (HA/QHA) is between 0.01–0.005 kcal/mol. If the change in the free energy difference
computed with Boltzmann weighted HA is fluctuating between -0.01–0.01 kcal/mol (spanned
by the grey bar) as N is increased, we can assume that the method is converged within the
error in the simulation packages.
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Figure 5: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
II (left) and III (right) of benzene relative to form I.
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Figure 6: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
II (left) and III (right) of piracetam relative to form I.
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Figure 7: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
III (left) and IV (right) of carbamazepine relative to form I.
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Figure 8: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
II of paracetamol relative to form I.
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Figure 9: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
II of adenine relative to form I.
8 Error evaluation of the approximations
In equation M5 the error for using an approximate ∆G(Tref ) can be computed as:
δ(∆(Gij(T )) = |∆Gaprox.ij (T )−∆Gij(T )| (8)
= TkB
(
∆fij(Tref )−∆fij(T aprox.ref )
)
+T
(
∆Gaprox.ij (T
aprox.
ref )
Taprox.ref
− ∆Gij(Tref )
Tref
)
(9)
Here we can move all temperature dependence to the left side of the equation to get a
constant value of the error for the approximation:
δ(∆(Gij(T ))
T
= kB
(
∆fij(Tref )−∆fij(T aprox.ref )
)
+
(
∆Gaprox.ij (T
aprox.
ref )
Taprox.ref
− ∆Gij(Tref )
Tref
)
(10)
Once we solve this, we can evaluate the error in the free energy at any temperature of
interest.
9 System Dependent Results
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Figure 10: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
β (top-left), γ (top-right), and δ (bottom) of pyrazinamide relative to form α.
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Figure 11: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
III of succinonitrile relative to form I.
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Figure 12: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
β of resorcinol relative to form α.
25
0 5 10 15 20 25 30 35 40
N
0.04
0.02
0.00
0.02
0.04
G
N
G
N
1 [
kc
al
/m
ol
] T=50.4 K
T=100.7 K
T=148.2 K
T=200.0 K
T=249.1 K
T=302.9 K
Figure 13: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
X of aripiprazole relative to form I.
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Figure 14: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
V of chlorpropamide relative to form I.
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Figure 15: The change in the polymorph free energy difference when using N and N − 1
frames using Boltzmann-weighted HA to complete the thermodynamic cycle for polymorph
II (top-left), III (top-right), and V (bottom) of tolbutamide relative to form I.
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Figure 16: Left) The polymorph free energy difference of benzene (form II relative to form
I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 17: Left) The polymorph free energy difference of benzene (form III relative to form
I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 18: Left) The polymorph free energy difference of piracetam (form II relative to
form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 19: Left) The polymorph free energy difference of piracetam (form III relative to
form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 20: Left) The polymorph free energy difference of carbamazepine (form III relative
to form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the
QHA values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 21: Left) The polymorph free energy difference of carbamazepine (form IV relative
to form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the
QHA values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 22: Left) The polymorph free energy difference of paracetamol (form II relative to
form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 23: Left) The polymorph free energy difference of adenine (form β relative to form
α) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 24: Left) The polymorph free energy difference of pyrazinamide (form β relative to
form α) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 25: Left) The polymorph free energy difference of pyrazinamide (form γ relative to
form α) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 26: Left) The polymorph free energy difference of pyrazinamide (form δ relative to
form α) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 27: Left) The polymorph free energy difference of succinonitrile (form III relative
to form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the
QHA values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 28: Left) The polymorph free energy difference of resorcinol (form β relative to form
α) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 29: Left) The polymorph free energy difference of aripiprazole (form X relative to
form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 30: Left) The polymorph free energy difference of chlorpropamide (form V relative
to form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the
QHA values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 31: Left) The polymorph free energy difference of tolbutamide (form II relative to
form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 32: Left) The polymorph free energy difference of tolbutamide (form III relative to
form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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Figure 33: Left) The polymorph free energy difference of tolbutamide (form V relative to
form I) using MD, QHA, and replacing ∆G(Tref ) from PSCP in equation 5 with the QHA
values for Tref every 10 K is shown. Right) The error in the ∆G(300K) is reported for
replacing ∆G(Tref ) from QHA with PSCP and using Boltzmann weighted HA. Each line of
the approximation in the left figure is color coded based off the reference temperature used.
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